CrowdfundedWealth

Saba Capital Lifts Its BlackRock TCP Capital (TCPC) Stake to 8.46% in a Nov 17, 2026 13D/A

ResearchBy Jorge17 min read6 SEC filings cited

Some links pay us a referral fee; each one says so. Disclosure

Quick answer

On November 17, 2026 Saba Capital Management, L.P., Saba Capital Management GP, LLC and Boaz R. Weinstein filed Amendment No. 2 to their Schedule 13D on BlackRock TCP Capital Corp. (Nasdaq: TCPC, CIK 1370755, accession 0001062993-26-006164): 7,094,640 common shares, 8.46% of 83,902,775, with the event dated November 16, 2026. That is up from 4,283,957 shares (5.11%) in the first 13D of October 14, 2026 and 5,986,934 (7.14%) on November 6. The amendment changes only Items 3, 5 and 7, and its Item 4, the purpose, reads “Not Applicable.” The only statement of what Saba may want is still the October 14 text. TCPC reported its third quarter on November 5, 2026: NAV $5.61 a share (from $6.58), net investment income $0.16 against the $0.17 dividend, and a fourth-quarter dividend of $0.17 declared. As of November 19, 2026 TCPC has filed nothing in response.

Key takeaways

  • Saba's stake has grown in three steps: 4,283,957 shares (5.11%) with the event dated October 9, 2026; 5,986,934 (7.14%) on November 4, 2026; 7,094,640 (8.46%) on November 16, 2026. All use the 83,902,775 shares TCPC reports. To reach 10% it would need 1,295,638 more shares (our arithmetic).
  • Amendment No. 2 says nothing new about purpose. Item 4 reads “Not Applicable.”, Item 6 reads “Not Applicable.”, and the filing names no meeting, nominee, tender, liquidation or alternative manager. What the October 14 13D says Saba may do (buy-backs, tenders, liquidations, a change of manager, board nominations, proxies) is a list of options, and it states no agreement with any third party.
  • The purchase schedules do not add up to the cover. The 52 purchase lines in the three Schedule As total 6,728,758 shares, 365,882 fewer than the 7,094,640 on the cover. The first two amendments reconcile; Amendment No. 2 leaves 334,082 shares unlisted, and its five lines (November 9, 10, 11, 16 and 17, 2026) list no trade on November 6, 12 or 13 (our arithmetic).
  • Saba pays about $4 a share. The lines run from $3.82 to $4.37; the weighted average is $4.047 (our arithmetic). Its largest day was November 5, 2026, the day TCPC reported: 698,126 shares at $4.10, 0.83% of the shares outstanding (our arithmetic). The November 17 line is 178,936 shares at $4.06.
  • TCPC's own numbers moved the same week. NAV per share was $5.61 at September 30, 2026 against $6.58 at June 30 (-14.7%, our arithmetic), $0.29 below the $5.90 that $6.58 less the company's August estimate of $0.68 gives (our arithmetic). Net investment income was $0.16 (adjusted $0.15) against the $0.17 dividend paid September 30. Non-accruals rose to 3.4% of the portfolio at fair value and 14.2% at cost. Net leverage was 0.16x.
  • The $0.17 fourth-quarter dividend was declared November 5, 2026, payable December 31, 2026 to holders of record on December 17, 2026. The stock closed at $4.00 on September 30, 2026, 71.3% of NAV (our arithmetic). The strategic review run with Keefe, Bruyette & Woods has produced no announced decision.

CSV · 140 rows

Saba Capital and BlackRock TCP Capital (TCPC): the three Schedule 13D filings, every purchase line, and TCPC's third quarter 2026 numbers

140 sourced rows: the three Saba filings (stake, percent, cost, event dates, Items 4 and 6), all 52 purchase lines with dates and prices, the share-count reconciliation, and TCPC's Q3 2026 results, NAV, dividend and strategic-review facts. Accession number on each row.

Filing alert · free

An email when BlackRock TCP Capital Corp. files with the SEC

An email the day BlackRock TCP Capital Corp. files something new, with the link to the document on the SEC site.

Our earlier TCPC stock, dividend and NAV page was written before the November 5 results and before the last two Saba filings. It carries the dividend history, the August 4 portfolio sale and the 2024 and 2025 numbers, and this page does not repeat them. It reads what has changed since: Saba's two amendments line by line, what the third-quarter filings say, and where each earlier figure now stands.

Saba's three filings side by side

Every Schedule 13D and 13D/A on TCPC so far was filed by the same three reporting persons. Before October 14, 2026 no Saba filing appears in the EDGAR list for TCPC's CIK, and the list shows no Schedule 13G by Saba at any time.

Item13D, October 14, 202613D/A No. 1, November 6, 202613D/A No. 2, November 17, 2026
Accession number0001062993-26-0053240001062993-26-0057910001062993-26-006164
Date of eventOctober 9, 2026November 4, 2026November 16, 2026
Shares (shared voting and dispositive power)4,283,9575,986,9347,094,640
Percent of class5.11%7.14%8.46%
Shares outstanding used83,902,775 (10-Q of August 6, 2026)83,902,775 (10-Q of November 5, 2026)83,902,775 (10-Q of November 5, 2026)
Item 3: total paid$17,149,739$24,194,242$27,360,638
Item 3 amount divided by cover shares (our arithmetic)$4.003$4.041$3.857
Items the filing amendsNew filing3, 5 and 73, 5 and 7
Item 4, purposeFull statement (see below)Not amended“Not Applicable.”
Item 6, contracts and arrangementsJoint filing agreement onlyNot amended“Not Applicable.”
Trades listed in Schedule A33 lines, August 14 to October 13, 202614 lines, October 14 to November 5, 20265 lines, November 9 to November 17, 2026

The share count is the cover page of each filing. The cost in Item 3 is Saba's own statement of what it paid, and it says it cannot determine how much was margin. The line that matters for a holder is Item 3 divided by the shares on the cover: it falls to $3.857 in the third filing, below the $4.047 weighted average of Saba's own purchase lines. The reason is in the reconciliation below.

What the purpose section says, and does not say

The October 14 13D is the only one of the three with a full Item 4. It says the reporting persons acquired the shares “because they believe that the Common Shares are undervalued and represent an attractive investment opportunity,” that they may talk to management, the board and other shareholders about matters that include “trading of the Common Shares at a discount to the Issuer's net asset value” and “timing of any potential liquidation of the Issuer,” and that they may “seek to influence the Issuer to engage in share buy-backs, tenders, and liquidations and/or to change its governance, investment strategy and/or investment manager.” It also says they may propose shareholder proposals, nominate directors and solicit proxies, that they have not agreed with any third party to act together, and that they may change course at any time.

That is standard 13D language for an activist position, and it is a list of things Saba may do. It contains no date, no named nominee, no proposed tender price and no named replacement manager. Amendment No. 2 does not add any. Its Item 4 reads “Not Applicable.” because the amendment does not amend that item; the October 14 text is therefore the latest statement of purpose. The first 13D/A and the second together add one new fact each time: more shares at about the same price. What Saba filed in a different fund, with a named alternative manager and a 2027 meeting, is on our Bluerock BPRE page; nothing of that kind appears in the TCPC filings as of November 19, 2026.

The purchase schedules, line by line

All 52 lines are buys, in the open market, at prices from $3.82 to $4.37. Schedule A of the first 13D covers the 60 days before filing, and the two amendments cover the time since the previous filing.

Schedule A ofLinesShares listedWeighted average price (our arithmetic)Largest line
13D, October 14, 2026334,252,157$4.003583,242 shares on September 28, 2026 at $3.98
13D/A No. 1, November 6, 2026141,702,977$4.137698,126 shares on November 5, 2026 at $4.10
13D/A No. 2, November 17, 20265773,624$4.093284,720 shares on November 9, 2026 at $4.12
All three526,728,758$4.047698,126 shares on November 5, 2026 (0.83% of shares outstanding)

The five lines of the newest schedule:

Trade dateShares boughtPrice
November 9, 2026284,720$4.12
November 10, 202619,347$4.10
November 11, 202652,453$4.12
November 16, 2026238,168$4.08
November 17, 2026178,936$4.06

The schedules show the pace: purchases on most trading days from August 14 to November 17, 2026, and the November 5, 2026 line is the largest of the 52, on the day TCPC published NAV of $5.61 and net investment income below its dividend. A purchase schedule is not a statement about why Saba bought on a given day.

The share count that does not reconcile

Adding the schedules to the covers works exactly once. The first amendment's cover (5,986,934) equals the first 13D's cover (4,283,957) plus the 1,702,977 in its Schedule A. The first 13D's cover is 31,800 shares above its own Schedule A, which covers the 60 days before filing. The second amendment breaks the pattern:

Check (our arithmetic)Shares
13D/A No. 1 cover, November 6, 20265,986,934
Plus the five lines in Schedule A of 13D/A No. 2773,624
Equals6,760,558
13D/A No. 2 cover, November 16, 20267,094,640
Shares on the cover that no schedule lists334,082
Item 3 cost increase, No. 2 minus No. 1$3,166,396
Schedule A of No. 2 summed (773,624 shares)$3,166,681

The cost in Item 3 moved by about what the five listed lines cost, while the cover moved by 334,082 more shares. Schedule A of the second amendment lists no trade on November 6, 12 or 13, 2026, and the filing does not say whether trades on those dates exist. We do not know which of the two numbers is complete; a further amendment may settle it. For anyone using the 8.46%, the denominator is 83,902,775 and the numerator is the cover figure, 7,094,640.

What TCPC filed on November 5, 2026

TCPC reported its third quarter in a 10-Q and an 8-K with its earnings release on November 5, 2026, the day Saba's largest purchase was made. The table sets each new figure against the earlier one the filings themselves print.

ItemEarlier comparison in the same filingsFigure from the November 5, 2026 filings
NAV per share$6.58 at June 30, 2026 (less the company's August estimate of $0.68 for the sale: $5.90, our arithmetic)$5.61 at September 30, 2026
Net investment income per share$0.32 in the September 2025 quarter$0.16 ($13.4 million); adjusted $0.15
Regular dividend$0.17 paid September 30, 2026$0.17 declared for the fourth quarter, payable December 31, 2026 to holders of record December 17, 2026
Non-accrual, fair value and cost1.6% and 7.4% at June 30, 20263.4% and 14.2% at September 30, 2026; twelve companies
Net leverage1.38x at June 30, 20260.16x at September 30, 2026
Net assets$552.0 million at June 30, 2026$471.0 million at September 30, 2026
Total assets$1.5 billion at June 30, 2026$816.5 million at September 30, 2026; investments $543.5 million across 126 companies
Loans in the continuation vehicle sold August 4, 2026About $523 million (August 8-K)About $524 million at closing (10-Q); $152.3 million purchase price for 95%; $63.7 million realized loss in the third quarter (earnings release)
Share repurchases$50 million program in force through April 30, 2027None in the third quarter

Two readings, both from the filings. First, the 8-K says net investment income of $0.16 “did not exceed the regular dividend of $0.17 per share paid on September 30, 2026”: $13.4 million against about $14.3 million of dividend on 83,902,775 shares, or 93.7% (our arithmetic). The third quarter's investment income of $28.5 million includes $0.08 a share from prepayment premiums and related accelerated discount and fee amortization, a one-off by nature, and the release shows a weighted-average yield on the total portfolio of 9.4% against 10.5% at June 30. Second, the quarter's net decrease in net assets from operations was $66.8 million, $0.80 a share, of which $80.1 million was net realized and unrealized loss; the filings tie $63.7 million of the realized loss to the continuation-vehicle transaction. The company estimated in August that the sale would cut NAV by $0.68 a share; NAV fell $0.97 a share over the quarter (our arithmetic).

The 10-Q says that on August 6, 2026 the board engaged Keefe, Bruyette & Woods “to consider strategic alternatives to maximize shareholder value,” which it says could include reinvesting, returning capital through buybacks, a strategic combination, or an orderly realization of portfolio assets. It adds that there is no assurance the company will pursue any of them. No filing by TCPC after November 5, 2026 appears on EDGAR as of November 19, 2026: no 8-K, no proxy material and no 40-33.

The price against NAV, on dated closes

TCPC's 10-Q gives one dated close for the quarter end: $4.00 on September 30, 2026, which is 71.3% of the $5.61 NAV on the same date (our arithmetic). The 10-Q's quarter table shows the third-quarter high close at $4.21 (25.0% below NAV) and the low at $3.13 (44.2% below). Saba's most recent Schedule A line, $4.06 on November 17, 2026, is 72.4% of the September 30 NAV; that NAV is seven weeks old and the company has not published a later one. The annualized $0.68 dividend is 16.7% of $4.06 (our arithmetic); a dividend is declared a quarter at a time.

What a holder can do with this

This is a checklist built from the filings, not a recommendation.

  • Use the filing for what it is. A 13D amendment says who owns what and what they have disclosed. Item 4 of the newest one is “Not Applicable.” Nothing in the filings sets a date for a vote, a tender or a proposal.
  • Watch the next filings, not the headlines. A further Schedule 13D/A, an 8-K, or a proxy filing under CIK 1370755 would be the first documents to name a proposal or a reply. The next periodic report is the annual report for the year ending December 31, 2026.
  • Separate the three numbers. The NAV of $5.61 is a September 30 figure, the dividend of $0.17 is declared for the December 31, 2026 payment, and the price Saba paid on November 17, 2026 is $4.06. They are not one measure.
  • Check the record date. The fourth-quarter dividend goes to holders of record on December 17, 2026 and is paid December 31, 2026.
  • Mind concentration and tax. A position that lost 14.7% of NAV in a quarter and sits at 72% of NAV in the market is a sizing question as much as a yield question. Distributions are reported on Form 1099-DIV, and a loss sale can trigger wash-sale rules. We do not give tax advice.
  • Read the strategic-review options as options. The 10-Q lists four; none has been chosen in a filing.

This is analysis of public documents, not investment, legal or tax advice. We do not give price targets or say whether to buy, sell or hold.

If a large share of your wealth sits in TCPC, or you are deciding what to do while Saba's stake and the board's review play out, a second opinion on your own numbers may help.

FAQ

Sources: Schedule 13D of Saba Capital Management, L.P., Saba Capital Management GP, LLC and Boaz R. Weinstein on BlackRock TCP Capital Corp. (CIK 1370755), filed October 14, 2026 (0001062993-26-005324), with its Exhibit 2 (Schedule A); Schedule 13D/A No. 1 of November 6, 2026 (0001062993-26-005791) and Exhibit 3; Schedule 13D/A No. 2 of November 17, 2026 (0001062993-26-006164), Exhibit 4 (Schedule A) and Exhibit 5; BlackRock TCP Capital Corp. Form 10-Q for the quarter ended September 30, 2026 (0001193125-26-448640); Form 8-K of November 5, 2026 with the earnings release in Exhibit 99.1 (0001193125-26-448654); Form 8-K of August 6, 2026 (0001193125-26-336845); the EDGAR filing list for CIK 1370755, read on November 19, 2026. Market prices are those printed in the 10-Q and in Saba's Schedule A, not a live quote. All ratios marked our arithmetic use the displayed source inputs.

Affiliate Disclosure: Some links are affiliate links. We may earn a commission at no extra cost to you. This does not affect our ratings. Learn more.